Dr. Kaili Liu is a dedicated scientist specializing in cancer immunotherapy, tumor microenvironment modulation, and single-cell transcriptomics. He earned his B.S. in Biological Sciences from Nanjing Agricultural University and his Ph.D. in Biochemistry and Molecular Biology from the Institute of Biophysics, Chinese Academy of Sciences. His early research in plant physiology and developmental neurobiology provided him with a strong interdisciplinary foundation, allowing him to approach biomedical challenges with a unique perspective. Dr. Liu’s work has significantly advanced the understanding of localized ablative immunotherapy (LAIT) and its role in reshaping the tumor microenvironment. His expertise in single-cell RNA sequencing and spatial transcriptomics has led to critical discoveries in immune cell interactions within tumors, contributing to the development of novel cancer treatment strategies. With over 40 peer-reviewed publications and more than 1100 citations, his research has gained international recognition and has been widely referenced by leading scientists in oncology and immunotherapy. Currently, Dr. Liu is a Research Assistant Professor at the Stephenson School of Biomedical Engineering, University of Oklahoma, where he continues to drive innovative research in cancer treatment and precision medicine.